ABSTRACT
OBJECTIVE: To analyze the safety and efficacy of skipping instrumentation at the C7 vertebra during posterior cervicothoracic fusions. METHODS: This is a retrospective chart review of 53 patients who underwent multilevel posterior cervical fusion between 2010 and 2015. Of 53 patients, 7 patients were instrumented at C7, serving as the control group, whereas the remaining 46 patients were not. Evaluation of efficacy was based on intraoperative complications, operative time, estimated blood loss, significant long-term complications, and radiographic evidence of fusion. RESULTS: Skipping the C7 level resulted in a significant reduction in estimated blood loss (321 ± 214 mL in the C7 bridge group vs. 531 ± 365 mL in the control group) and an insignificant, but decreased, reduction in operative time (155 ± 70 minutes in the C7 bridge group vs. 194 ± 66 minutes in the control group). Two intraoperative complications were noted in the C7 group, and 1 intraoperative complication was noted in the control group. In addition, patients skipped at C7 maintained sagittal balance with fusion rates similar to control patients at follow-up. No significant long-term complications were found in both groups. CONCLUSIONS: Skipping C7 in a multilevel posterior cervicothoracic fusion demonstrates significantly reduced estimated blood loss and faster operative times compared with the control group. In addition, postoperative assessment yielded similar rates of fusion in both groups. Serious negative outcomes of skipping C7 were not found in this retrospective study. Our study results illustrate the clinical benefits of skipping instrumentation at C7 to minimize surgical risk in patients undergoing posterior cervical fusion across the cervicothoracic junction.
Subject(s)
Cervical Vertebrae/surgery , Spinal Diseases/surgery , Spinal Fusion/adverse effects , Spinal Fusion/methods , Thoracic Vertebrae/surgery , Aged , Aged, 80 and over , Female , Humans , Intraoperative Complications/etiology , Male , Middle Aged , Postoperative Complications/etiology , Retrospective Studies , Treatment OutcomeABSTRACT
BACKGROUND: Venous outflow obstructions are rare anatomic findings that can appear with symptoms of elevated intracranial pressure, including headache and vision loss, and can be mistaken for more common diagnoses, such as idiopathic intracranial hypertension (IIH) or cerebral venous sinus thrombosis (CVST). Although venous outflow obstructions have been reported in rare bone dysplasias and congenital abnormalities, to date they have not been reported in renal osteodystrophy (ROD), a relatively common disorder seen in patients with chronic kidney disease. CASE DESCRIPTION: In this case, the authors describe a patient with marked intracranial hypertension from jugular foramen stenosis secondary to ROD. After diagnosis by CT and magnetic resonance venography, catheter venography confirmed an osseus band around the left jugular bulb, and a 40-mm Hg pressure gradient across the stenotic foramen. The patient subsequently underwent ventriculoperitoneal shunting and optic nerve sheath fenestration with symptom improvement. The postoperative course was significant for development of CVST, necessitating treatment. CONCLUSIONS: This report reviews the presentation, pathology, and neurosurgical treatment of patients with ROD and venous outflow obstructions, and explores the differential diagnoses of outflow obstructions, IIH, and CVST. To our knowledge, this is the first report of intracranial hypertension from jugular foramen stenosis secondary to renal osteodystrophy.
Subject(s)
Chronic Kidney Disease-Mineral and Bone Disorder/complications , Intracranial Hypertension/surgery , Sinus Thrombosis, Intracranial/surgery , Ventriculoperitoneal Shunt , Adult , Constriction, Pathologic/complications , Constriction, Pathologic/diagnostic imaging , Humans , Intracranial Hypertension/diagnostic imaging , Intracranial Hypertension/etiology , Magnetic Resonance Imaging , Male , Sinus Thrombosis, Intracranial/diagnostic imaging , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
Cervical kyphotic deformity represents a difficult to treat pathology often arising from multiple factors including, but not limited to, traumatic injuries, degenerative changes, and ankylosing spondylitis. Furthermore, treatment of these deformities becomes increasingly difficult with any preexisting instrumentation. Currently, several options exist to treat these severe deformities, with the Smith-Petersen osteotomy and C-7 pedicle subtraction osteotomy being the most frequently used approaches. However, these techniques come with significant risk to the patient including nerve root injury as well as compression of the vertebral arteries. The authors here report on a series of 4 patients with rigid cervical deformity who underwent T-1 pedicle subtraction osteotomy. The authors review the relevant literature and provide a novel, less risky, and potentially more corrective approach for treating cervical deformities.
Subject(s)
Cervical Vertebrae/surgery , Kyphosis/surgery , Osteotomy , Thoracic Vertebrae/surgery , Aged , Cervical Vertebrae/diagnostic imaging , Female , Follow-Up Studies , Humans , Intraoperative Neurophysiological Monitoring , Kyphosis/diagnostic imaging , Middle Aged , Osteotomy/methods , Retrospective Studies , Thoracic Vertebrae/diagnostic imagingABSTRACT
The anterior cingulate gyrus (ACG) is a continued focus of research as its exact role in brain function and vast connections with other anatomical locations is not fully understood. A review of the literature illustrates the role the ACG likely plays in cognitive and emotional processing, as well as a modulating role in motor function and goal-oriented behaviors. While lesions of the cingulate gyrus are rare, each new case broadens our understanding of its role in cognitive neuroscience and higher order processing. The authors present the case of an 8-year-old boy with a 1-month history of staring spells, agitated personality, and hyperphagia notable for the consumption of paper, who was found to have a 3-cm tumor in the left ACG. Following surgical resection of the tumor, his aggressive behavior and pica were ameliorated and the patient made an uneventful recovery, with no evidence of recurrence over the last 6 years since surgical resection. Here we discuss a unique behavioral presentation of pica, along with a review of the current literature, to illustrate functions of the ACG relevant to the location of the lesion.
Subject(s)
Gyrus Cinguli/surgery , Oligodendroglioma/surgery , Pica/etiology , Brain Neoplasms/surgery , Child , Gyrus Cinguli/pathology , Humans , Magnetic Resonance Imaging , Male , Oligodendroglioma/pathology , Treatment OutcomeABSTRACT
Nonaccidental head injury, as seen in domestic child abuse cases, is often associated with spinal injury, and spinal subdural hematoma is the most frequent diagnosis. While spinal epidural hematomas are a rare occurrence, the incidence of spontaneous epidural hematomas occurring in nonaccidental head injury patients is even lower. Epidural hematomas often result in acute focal neurological deficits necessitating emergent neurosurgical intervention. In patients without focal neurological deficits, conservative management may allow for spontaneous resolution of the epidural hematoma. The authors present the case of a 2-year-old boy with a large spinal epidural hematoma resulting after an event of nonaccidental injury, specifically, domestic child abuse. This patient exhibited no focal neurological deficits and was managed conservatively without surgical clot evacuation. On a follow-up visit, repeat imaging studies demonstrated a stable resolution of spinal epidural hematoma, providing further support for the safety of conservative management in these patients.
Subject(s)
Child Abuse/diagnosis , Hematoma, Epidural, Spinal/diagnostic imaging , Hematoma, Epidural, Spinal/etiology , Child, Preschool , Humans , Male , Remission, SpontaneousABSTRACT
The number of peripheral nerve stimulation (PNS) indications, targets, and devices is expanding, yet the development of the technology has been slow because many devices used for PNS do not have formal regulatory approval. Manufacturers have not sought Food and Drug Administration (FDA) approval for PNS devices because of a perceived lack of interest amongst practitioners and patients. Without FDA approval, companies cannot invest in marketing to educate the implanters and the patients about the benefits of PNS in the treatment of chronic pain. Violation of this has resulted in governmental investigation and prosecution. Most of the PNS devices currently used to treat chronic pain are FDA approved for epidural spinal cord stimulation. Many of the complications seen in PNS surgery can be attributed to the lack of purpose-built hardware with FDA approval. Despite the lack of regulatory approval, there are insurance companies that approve PNS procedures when deemed medically necessary. As the targets and indications for PNS continue to expand, there will be an even greater need for customized technological solutions. It is up to the medical device industry to invest in the design and marketing of PNS technology and seek out FDA approval. Market forces will continue to push PNS into the mainstream and physicians will increasingly have the choice to implant devices specifically designed and approved to treat chronic peripheral nerve pain.
Subject(s)
Device Approval/legislation & jurisprudence , Electric Stimulation Therapy/standards , Pain Management/standards , Peripheral Nerves/surgery , Electric Stimulation Therapy/methods , Humans , Pain Management/methods , Peripheral Nerves/physiology , United StatesABSTRACT
The most commonly described indications for surgical management of closed depressed skull fractures are hematoma evacuation and repair of extensive cosmetic deformity. Venous sinus injury, which occurs in a subset of depressed skull fractures, is not typically listed as an indication for surgical treatment due to the potential for major venous hemorrhage associated with surgery near these structures. However, if patients exhibit signs and symptoms of intracranial hypertension and radiographic findings demonstrate sinus compromise, surgical elevation of the depressed skull fragments is indicated. The authors present the case of a 25-year-old woman with a depressed skull fracture secondary to a gunshot wound with symptomatic compromise in venous outflow of the posterior one-third of the superior sagittal sinus. The patient was treated with surgical decompression via bilateral craniectomy along with intracranial pressure-lowering medical therapy and had almost full resolution of her presenting symptoms with documented improvement in flow through the superior sagittal sinus. While the use of surgical treatment for these types of injuries is highly debated, the authors demonstrate here that safe, effective surgical management of these patients is possible and that surgical decompression should always be considered in the case of symptomatic venous sinus flow obstruction.
Subject(s)
Cranial Sinuses/injuries , Decompression, Surgical/methods , Decompressive Craniectomy/methods , Head Injuries, Penetrating/surgery , Superior Sagittal Sinus/surgery , Wounds, Gunshot/surgery , Adult , Cranial Sinuses/diagnostic imaging , Female , Head Injuries, Penetrating/diagnostic imaging , Hemodynamics/physiology , Humans , Intracranial Hypertension/physiopathology , Intracranial Hypertension/surgery , Superior Sagittal Sinus/diagnostic imaging , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
Vascular endothelial growth factor (VEGF) is a key molecule that orchestrates the formation and function of vascular networks. Impaired regulation of angiogenesis is implicated in a number of pathologic states. For instance, neoplasias exhibit uncontrolled angiogenesis, whereas ischemia and states of vascular insufficiency involve reduced VEGF activity. As the role of VEGF has been elucidated in these disease processes, its therapeutic role has been developed. The Food and Drug Administration has approved several anti-VEGF agents for treating colorectal, lung, and kidney cancer. VEGF-inducing agents have also been used experimentally to induce angiogenesis in patients with critical limb ischemia. As more knowledge is gathered about the biology of VEGF and its receptors, there is greater promise for therapeutic modulation of VEGF expression. The purpose of this review is to describe the various therapeutic and biologic factors that regulate the expression of VEGF.